SCHEMBL23346145

SCHEMBL23346145

COC[C@H]1C[C@@H](C(=O)O)N(CC(=O)OCc2ccccc2)C1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 2/20 0.46
ALDH1A1 P00352 5/20 0.40
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
FKBP1A P62942 2/20 0.39
CYP2C9 P11712 3/20 0.39
CYP2C19 P33261 3/20 0.39
CYP1A2 P05177 3/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTR2C P28335 1/20 0.38
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37
PREP P48147 2/20 0.37
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26404221 0.83 ALDH1A1 (0.44) AGTR2ALDH1A1MAPK1L3MBTL1CYP2C9
SCHEMBL24652907 0.82 ALDH1A1 (0.45) AGTR2ALDH1A1MAPK1L3MBTL1CYP2C9
SCHEMBL20811300 0.82 ALDH1A1 (0.45) AGTR2ALDH1A1MAPK1L3MBTL1CYP2C9
SCHEMBL24066812 0.82 ALDH1A1 (0.45) AGTR2ALDH1A1MAPK1L3MBTL1CYP2C9
SCHEMBL28374760 0.81 AGTR2 (0.56) AGTR2FKBP1ANPC1RAB9ASMN1; SMN2
SCHEMBL18746168 0.77 NPC1 (0.43) ALDH1A1MAPK1L3MBTL1FKBP1ACYP2C9
SCHEMBL18746181 0.75 CPB1 (0.43) ALDH1A1MAPK1L3MBTL1FKBP1ACYP2C9
SCHEMBL29303854 0.75 POLB (0.46) ALDH1A1MAPK1L3MBTL1FKBP1ACYP2C9
SCHEMBL22404766 0.75 POLB (0.46) ALDH1A1MAPK1L3MBTL1FKBP1ACYP2C9
SCHEMBL25832810 0.75 POLB (0.46) ALDH1A1MAPK1L3MBTL1FKBP1ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139493-A1 PREPARATION OF VELPATASVIR AND DERIVATIVE THEREOF SHANGHAI FOREFRONT PHARMACEUTICAL CO LTD (CN) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139493-A1 PREPARATION OF VELPATASVIR AND DERIVATIVE THEREOF SAMHD1, TYMP, PNP AGTR2 2733/4885ALDH1A1 393/4885MAPK1 2512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.